A61K 39/235
Adenoviridae
A61K39/235 (Adenoviridae) appears on 123 US grants and 227 published applications in this corpus.
Search patents in A61K- Granted patents
- 123
- Published applications
- 227
- Assignees
- 129
- Inventors
- 400
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 0 | 0 |
| 2003 | 2 | 1 |
| 2004 | 0 | 3 |
| 2005 | 0 | 4 |
| 2006 | 0 | 3 |
| 2007 | 1 | 1 |
| 2008 | 2 | 10 |
| 2009 | 1 | 6 |
| 2010 | 2 | 4 |
| 2011 | 1 | 5 |
| 2012 | 2 | 6 |
| 2013 | 2 | 6 |
| 2014 | 1 | 11 |
| 2015 | 4 | 14 |
| 2016 | 11 | 15 |
| 2017 | 7 | 11 |
| 2018 | 5 | 14 |
| 2019 | 10 | 14 |
| 2020 | 7 | 23 |
| 2021 | 7 | 12 |
| 2022 | 21 | 19 |
| 2023 | 12 | 14 |
| 2024 | 8 | 13 |
| 2025 | 11 | 8 |
| 2026 | 0 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treating retinal disorders11 Nov 2025US 12,467,066 B2UCL Business PLC
- Cross-reactive epitope for multiple sclerosis14 Oct 2025US 12,440,544 B2The Board of Trustees of the Leland Stanford Junior University
- tFIBER protein fragment of avian egg drop syndrome virus and vaccine composition prepared thereof, preparation method and use14 Oct 2025US 12,440,551 B2Pulike Biological Engineering, Inc.
- Nucleic acids encoding human endogenous retrovirus K (HERV-k) envelope proteins containing modified immunosuppressive domains (ISD) and uses thereof19 Aug 2025US 12,390,522 B2Inprother Aps
- Methods and compositions for producing an adenovirus vector for use with multiple vaccinations29 Jul 2025US 12,370,250 B2Etubics Corporation
- Adenoviral vector vaccine, and preparation method and use thereof10 Sep 2026US 2026/0265702 A1Cansino Biologics Inc.
- Vaccine for protection against leptospira serovar australis9 Jul 2026US 2026/0191941 A1Intervet Inc.
- Method of reducing adenoviral vector-associated tts2 Jul 2026US 2026/0183353 A1Beth Israel Deaconess Medical Center, Inc.
- Stabilization of virus-based therapeutic agent14 May 2026US 2026/0130983 A1Elarex Inc.
- Nucleic acids encoding human endogenous retrovirus k (herv-k) envelope proteins containing modified immunosuppressive domains (isd) and uses thereof19 Mar 2026US 2026/0077031 A1Inprother Aps
Most cited
By later US patents
- Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use102US 7,247,472 B2The Trustees of the University of Pennsylavania · 2007
- Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use50US 8,105,574 B2The Trustees of the University of Pennsylvania · 2012
- Antiviral vaccines with improved cellular immunogenicity48US 9,017,691 B2Beth Israel Deaconess Medical Center, Inc. · 2015
- Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use46US 8,603,459 B2The Trustees of the University of Pennsylvania · 2013
- Synthetic glucopyranosyl lipid adjuvants26US 8,722,064 B2Infectious Disease Research Institute · 2014